Human-in-the-Loop Causal Discovery under Latent Confounding using Ancestral GFlowNets

Structure learning is the crux of causal inference. Notably, causal discovery (CD) algorithms are brittle when data is scarce, possibly inferring imprecise causal relations that contradict expert knowledge -- especially when considering latent confounders. To aggravate the issue, most CD methods do not provide uncertainty estimates, making it hard for users to interpret results and improve the inference process. Surprisingly, while CD is a human-centered affair, no works have focused on building methods that both 1) output uncertainty estimates that can be verified by experts and 2) interact with those experts to iteratively refine CD. To solve these issues, we start by proposing to sample (causal) ancestral graphs proportionally to a belief distribution based on a score function, such as the Bayesian information criterion (BIC), using generative flow networks. Then, we leverage the diversity in candidate graphs and introduce an optimal experimental design to iteratively probe the expert about the relations among variables, effectively reducing the uncertainty of our belief over ancestral graphs. Finally, we update our samples to incorporate human feedback via importance sampling. Importantly, our method does not require causal sufficiency (i.e., unobserved confounders may exist). Experiments with synthetic observational data show that our method can accurately sample from distributions over ancestral graphs and that we can greatly improve inference quality with human aid.

The FeatureCloud AI Store for Federated Learning in Biomedicine and Beyond

Machine Learning (ML) and Artificial Intelligence (AI) have shown promising results in many areas and are driven by the increasing amount of available data. However, this data is often distributed across different institutions and cannot be shared due to privacy concerns. Privacy-preserving methods, such as Federated Learning (FL), allow for training ML models without sharing sensitive data, but their implementation is time-consuming and requires advanced programming skills. Here, we present the FeatureCloud AI Store for FL as an all-in-one platform for biomedical research and other applications. It removes large parts of this complexity for developers and end-users by providing an extensible AI Store with a collection of ready-to-use apps. We show that the federated apps produce similar results to centralized ML, scale well for a typical number of collaborators and can be combined with Secure Multiparty Computation (SMPC), thereby making FL algorithms safely and easily applicable in biomedical and clinical environments.

Privacy-preserving Artificial Intelligence Techniques in Biomedicine

Artificial intelligence (AI) has been successfully applied in numerous scientific domains including biomedicine and healthcare. Here, it has led to several breakthroughs ranging from clinical decision support systems, image analysis to whole genome sequencing. However, training an AI model on sensitive data raises also concerns about the privacy of individual participants. Adversary AIs, for example, can abuse even summary statistics of a study to determine the presence or absence of an individual in a given dataset. This has resulted in increasing restrictions to access biomedical data, which in turn is detrimental for collaborative research and impedes scientific progress. Hence there has been an explosive growth in efforts to harness the power of AI for learning from sensitive data while protecting patients' privacy. This paper provides a structured overview of recent advances in privacy-preserving AI techniques in biomedicine. It places the most important state-of-the-art approaches within a unified taxonomy, and discusses their strengths, limitations, and open problems.

The Virtual Doctor: An Interactive Artificial Intelligence based on Deep Learning for Non-Invasive Prediction of Diabetes

Artificial intelligence (AI) will pave the way to a new era in medicine. However, currently available AI systems do not interact with a patient, e.g., for anamnesis, and thus are only used by the physicians for predictions in diagnosis or prognosis. However, these systems are widely used, e.g., in diabetes or cancer prediction. In the current study, we developed an AI that is able to interact with a patient (virtual doctor) by using a speech recognition and speech synthesis system and thus can autonomously interact with the patient, which is particularly important for, e.g., rural areas, where the availability of primary medical care is strongly limited by low population densities. As a proof-of-concept, the system is able to predict type 2 diabetes mellitus (T2DM) based on non-invasive sensors and deep neural networks. Moreover, the system provides an easy-to-interpret probability estimation for T2DM for a given patient. Besides the development of the AI, we further analyzed the acceptance of young people for AI in healthcare to estimate the impact of such system in the future.

FRI - Feature Relevance Intervals for Interpretable and Interactive Data Exploration

Most existing feature selection methods are insufficient for analytic purposes as soon as high dimensional data or redundant sensor signals are dealt with since features can be selected due to spurious effects or correlations rather than causal effects. To support the finding of causal features in biomedical experiments, we hereby present FRI, an open source Python library that can be used to identify all-relevant variables in linear classification and (ordinal) regression problems. Using the recently proposed feature relevance method, FRI is able to provide the base for further general experimentation or in specific can facilitate the search for alternative biomarkers. It can be used in an interactive context, by providing model manipulation and visualization methods, or in a batch process as a filter method.